20
Lek Pharmaceuticals Dd, based in Slovenia, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is APREMILAST, with a corresponding US DMF Number 31809.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 16, 2017, and payment made on September 11, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II